课题基金 / 基金详情

Research Education About Cancer and Health (REACH) Core

Research Education About Cancer and Health (REACH) Core
关于癌症与健康的研究教育 (REACH) 核心
批准号:
10756839
负责人:
Julian A Simon
金额:
$16.57万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-09-30 至 2028-08-31

项目摘要

项目成果

Julian A Simon的其他基金

相关文献

中文摘要
翻译
摘要 癌症与健康合作研究教育(REACH)核心将提供研究 开展癌症和健康差距方面的教育活动,并培养未来的科学家为 生物医学研究队伍的多样化。REACH CORE取得了非凡的成功 在培训本科生和研究生方面,包括来自历史上被排斥的社区的个人 (HECS)在前几个U54伙伴关系供资周期中。根据其实施各种 研究性教育计划,如本科生(NMSU本科生癌症研究实习; CRI-U)和毕业生(NMSU毕业生癌症研究实习;CRI-G)研究实习, 研究生健康差异课程(华盛顿大学公共卫生学院)和健康 差异实地经验(在U54-IV中更名为卫生公平实地经验),伙伴关系将 实施以癌症和/或健康为重点的综合生物医学研究教育计划 跨不同学术水平的差异研究,以使科学劳动力多样化,为 生物医学和人口健康研究。该伙伴关系还将提供同时和持续的支持。 在所有参与者中实现学术和职业目标。要衡量的形成性评估 研究教育活动的优势和信息领域的改进将与 规划与评估核心。伙伴关系将继续使用长期跟踪工具,以提供可持续的 支持参与者并评估活动的影响和效果。响应过去节目 内部咨询委员会和外部方案指导的评价和建议 委员会,提出了一系列活动,优先考虑当前促进和提高癌症的需求 这两所大学的研究教育都集中在本科生和研究生。 REACH核心将实施跨学术水平和学科的教育计划;提供支持 对于学员的目标实现,确定个人特定的需求和兴趣、机会以及 职业发展的潜在障碍;为实习生创造社区意识的设计经验 既属于伙伴关系内部,也属于更广泛的科学界,以及; 评估研究教育活动的有效性,包括长期跟踪,以确定 创新的机会和改进的需要,同时满足参与者的多样化需求。这些 活动将有助于该伙伴关系的目标,即使生物医学劳动力多样化,创造更多 包容性和积极的研究环境,增强癌症健康公平。
英文摘要
ABSTRACT The Partnership Research Education About Cancer and Health (REACH) Core will deliver research education activities in cancer and health disparities and prepare future scientists to contribute to the diversification of the biomedical research workforce. The REACH Core has demonstrated exceptional success in training undergraduate and graduate students, including individuals from Historically Excluded Communities (HECs) in previous U54 Partnership funding cycles. Based on its experience implementing a variety of research education programs such as undergraduate (Cancer Research Internship for NMSU Undergraduates; CRI-U) and graduate (Cancer Research Internship for NMSU Graduates; CRI-G) research internships, Graduate Health Disparities Course (University of Washington, School of Public Health), and the Health Disparities Field Experience (renamed the Health Equity Field Experience in the U54-IV), the Partnership will implement integrated biomedical research education programs with an emphasis on cancer and/or health disparities research, across a spectrum of academic levels to diversify the scientific workforce contributing to biomedical and population health research. The Partnership will also provide concurrent and on-going support for academic and professional goal attainment among all its participants. Formative assessments to measure strengths and inform areas for improvement of research education activities will be carried out with the Planning & Evaluation Core. The Partnership will continue to use long-term tracking tools to offer sustained support to participants and evaluate impact and effectiveness of activities. In response to past program evaluation and recommendations from the Internal Advisory Committee and external Program Steering Committee, a portfolio of activities is proposed that prioritize the current needs to promote and heighten cancer research education that is focused on undergraduate and graduate students at both institutions. The REACH Core will implement education programs across academic levels and disciplines; provide support for trainees’ goal attainment that identifies individual-specific needs and interests, opportunities as well as potential barriers to career advancement; design experiences for trainees that create a sense of community and belonging both within the Partnership and more broadly in the larger scientific community, and; conduct assessments of research education activities’ effectiveness, including long-term tracking, to identify opportunities for innovation and needs for improvement while meeting the diverse needs of participants. These activities will contribute to the Partnership’s Aims of diversifying the biomedical workforce, creating a more inclusive and affirmative research environment and enhancing cancer health equity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Inhibition of B-Catenin Signaling for Treatment of Hepatocellular Carcinoma
Chemoprotection Against Aminoglycoside-Induced Ototoxicity
Chemoprotection Against Aminoglycoside-Induced Ototoxicity